Racial Differences in BRAF/KRAS Mutation Rates and Survival in Stage III Colon Cancer Patients

BACKGROUND: It is unknown if, after controlling for clinicopathologic variables and treatment, racial disparities in colon cancer outcomes persist. Molecular marker analysis in North American patients comparing Asians with other races has not been reported. METHODS: BRAF (V600E) and KRAS mutations w...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Natl Cancer Inst
Main Authors: Yoon, Harry H., Shi, Qian, Alberts, Steven R., Goldberg, Richard M., Thibodeau, Stephen N., Sargent, Daniel J., Sinicrope, Frank A.
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2015
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5758035/
https://ncbi.nlm.nih.gov/pubmed/26160882
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djv186
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares